Laxatives and Purgatives: Mechanisms and 2023 AGA–ACG Constipation Guidelines

Medical education review — 10 November 2026. Not a substitute for individualized diagnosis, prescribing advice or local guidance. Overview Constipation may reflect slow colonic transit, pelvic-floor dysfunction, medications or systemic illness. Initial assessment should identify alarm features such as rectal bleeding, anemia, unexplained weight loss, severe progressive pain or obstruction before recommending chronic laxative use…

Read Full News

Prokinetic Drugs: Gastroparesis Treatment, Mechanisms and Safety

Evidence-informed educational review. Updated 10 November 2026. Follow current local product labeling and individualized clinical guidance. Feeling full after a few bites, nausea and vomiting can occur in gastroparesis. Before choosing a prokinetic, establish that solid food empties slowly and exclude a mechanical obstruction. The 2025 American Gastroenterological Association (AGA) guideline favours a four-hour gastric…

Read Full News

Proton Pump Inhibitors: Mechanisms, Clinical Indications, Optimal Dosing and Safety

Evidence-informed educational review. Updated 10 November 2026. Follow current local product labeling and individualized clinical guidance. Classification and mechanism Omeprazole, esomeprazole, lansoprazole, dexlansoprazole, pantoprazole and rabeprazole are substituted benzimidazole prodrugs. Dexlansoprazole is the R-enantiomer of lansoprazole. Drug activation occurs in the acidic canaliculus of the gastric parietal cell, where active sulfenamide intermediates bind the luminal…

Read Full News

Peptic Ulcer Disease: Acid Suppression, H. pylori Eradication and NSAID Risk

Evidence-informed educational review. Updated 10 November 2026. Follow current local product labeling and individualized clinical guidance. For a gastric or duodenal ulcer, drug treatment has two jobs: allow the mucosa to heal and remove the cause of injury. Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs (NSAIDs) are common causes and can coexist. Ask specifically about…

Read Full News

Antitussives and Expectorants: Cough Medicines, Mechanisms and Safety

Evidence-informed educational review. Updated 10 November 2026. Follow current local product labeling and individualized clinical guidance. An acute cough from a respiratory infection often improves within three to four weeks. Before recommending a cough medicine, ask how long the cough has lasted, whether it brings up substantial sputum and whether the person is breathless or…

Read Full News

COPD Pharmacology: GOLD 2026 Inhalers, Exacerbations and Emerging Treatments

Medical education article updated 10 November 2026. Prescribing should follow current local clinical guidelines and product information. Overview Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and airflow obstruction. Confirm diagnosis with post-bronchodilator spirometry showing FEV1/FVC below 0.70 in the appropriate clinical context. Pharmacotherapy reduces symptoms and exacerbations but must accompany smoking…

Read Full News

Asthma Drugs: GINA 2026 ICS-Formoterol, Biologics and Safe Treatment

Medical education article updated 10 November 2026. Prescribing should follow current local clinical guidelines and product information. Overview Asthma involves variable respiratory symptoms and variable expiratory airflow limitation. Treatment goals are symptom control and prevention of severe attacks, loss of lung function and medication harms. GINA 2026 emphasizes objective confirmation of the diagnosis, inhaler training…

Read Full News

Bronchodilators: Beta-2 Agonists, Muscarinic Antagonists and Clinical Safety

Medical education article updated 10 November 2026. Prescribing should follow current local clinical guidelines and product information. Overview Bronchodilators relax bronchial smooth muscle and improve airflow in asthma and COPD. They relieve obstruction but do not universally control airway inflammation: this distinction is especially important in asthma, where inhaled corticosteroid (ICS)-containing therapy is needed to…

Read Full News

Serotonin Receptor Agonists and Antagonists: Classification, Uses and Safety

Medical education article updated 10 November 2026. Prescribing should follow current local clinical guidelines and product information. Introduction and receptor classification Serotonin (5-hydroxytryptamine, 5-HT) signals through multiple receptor families. Most are G-protein-coupled receptors; 5-HT3 is a ligand-gated cation channel. Pharmacologic effects depend on receptor subtype and tissue: 5-HT1 receptors generally couple to Gi/o, 5-HT2 to…

Read Full News

Prostaglandins and Eicosanoids: Biosynthesis, Receptors and Therapeutic Drugs

Medical education article updated 10 November 2026. Prescribing should follow current local clinical guidelines and product information. Overview Eicosanoids are short-lived lipid mediators made from polyunsaturated fatty acids, classically arachidonic acid. They include prostaglandins, prostacyclin, thromboxanes, leukotrienes and lipoxins, with important roles in inflammation, vascular tone, platelet function, reproduction, renal perfusion and airway biology [1]….

Read Full News